1. Bross PF, Beitz J, Chen G, et al. Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia.Clin Cancer Res. 2001;7:1490–1496.
2. CTC v2.0 and CTCAE v3.0 Webpage. National Cancer Institute. Available at: http://ctep.cancer.gov/reporting/ctc.html. Accessed March 1, 2006.
3. Official Website. The International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Available at: http://www.ich.org. Accessed March 1, 2006.
4. Floyd JD, Nguyen DT, Lobins RL, Bashir Q, Doll DC, Perry MC. Cardiotoxicity of cancer therapy.J Clin Oncol. 2005;23:7685–7696.
5. Yeh ET, Tong AT, Lenihan DJ, et al. Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management.Circulation. 2004;109:3122–3131.